Sunday, December 5, 2010

Diabetes Drug Could Be A Potential Treatment For Alzheimer's - Alzheimer's Society Comment


Main Category: Alzheimer's / Dementia
Also Included In: Diabetes
Article Date: 24 Nov 2010 - 1:00 PST window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend ? printer icon printer friendly ? write icon opinions ?
not yet ratednot yet rated
New research claims that a drug commonly used in the treatment of type II diabetes can help treat Alzheimer's disease.

A paper published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) found that metformin can reduce the amount of the abnormal tau protein in the brains of mice. Healthy nerve cells produce tau but in Alzheimer's, the abnormal form is produced which does not function correctly.

Alzheimer's Society comment:

'Previous research has suggested that metformin reduces the risk of dementia in diabetic people, and this study provides some understanding of why this might be. The fact that the drug is safe for humans means it could potentially be tested more quickly than a completely new drug. However, further research is needed to fully understand the link between diabetes and Alzheimer's.'

'A million more people are set to develop dementia in the next 10 years. It is important that people maintain a healthy lifestyle in order to reduce their risk and that greater investment in dementia research is made to further our understanding of the condition.'

Dr Anne Corbett
Research Communications Manager

Research Reference: Professor Susann Schweiger, et al. 'The Biguanidemetformin acts on tauphosphorylation via mTOR/PP2vAsignalling', Proceedings of the National Academy of Sciences of the United States of America, November 2010.

Source:
Alzheimer's Society

Please rate this article:
(Hover over the stars
then click to rate) Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

No comments:

Post a Comment